BJMO - 12, issue 3, february 2018
T. Vandamme MD, I. Maurissen , W. Lybaert MD, M. Simoens , P. Abrams , A. Driessen MD, PhD, B. Op De Beeck , W. Demey MD, T. Rondou , M. Ulenaers , G. Vanhoutte , M. Peeters MD, PhD, Steering Commitee , NET-specialists
BJMO - volume 11, issue 7, november 2017
W. Lybaert MD
In this article, the most important new studies presented at ESMO 2017 in Madrid in early (EBC) and metastatic breast cancer (MBC) are summarised. In EBC, 5 topics are highlighted: integration of PI3K and CDK4/6 inhibition in the neoadjuvant treatment of oestrogen receptor positive (ER+) EBC, dual endocrine blockade as adjuvant treatment in ER+ EBC, escalated adjuvant treatment in human epidermal growth factor receptor positive (HER2+) EBC and small tumours that can also show an aggressive course. In MBC, 4 topics are discussed: predicting immunogenicity in MBC, abscopal effect in MBC, confirmed benefit of PARP inhibitors in BRCA mutated MBC and CDK4/6 inhibition in first-line MBC.
(BELG J ONCOL 2017;11(7):309–314)
Read moreBJMO - volume 11, issue 3, may 2017
W. Lybaert MD, M. Simoens , W. Demey MD, F. van Fraeyenhove MD, T. Vandamme MD, L. De Backer , M. Peeters MD, PhD
Barcelona, 8-10 March 2017.
(BELG J MED ONCOL 2017;11(3):129–133)
Read moreBJMO - 2017, issue 3, february 2017
W. Lybaert MD, T. Vandamme MD, M. Simoens , P. Abrams , W. Demey MD, T. Rondou , M. Ulenaers , G. Vanhoutte , M. Peeters MD, PhD, NET specialists NETwerk Steering Committee
BJMO - 2017, issue 3, february 2017
L. Jongen , P. Neven MD, PhD, A. Lintermans , K. Van Asten MSc, C. Blomme , D. Lambrechts PhD, A. Poppe , H. Wildiers MD, PhD, A.S. Dieudonné , J. Decloedt , P. Berteloot , D. Verhoeven MD, PhD, M. Joerger , P. Vuylsteke MD, W. Wyendaele , M. Casteels , S. Van Huffel , W. Lybaert MD, J. Van Ginderachter , R. Paridaens , I. Vergote , V. Dezentjé , B. Van Calster PhD, H-J. Guchelaar
BJMO - 2017, issue 3, february 2017
W. Lybaert MD, T. Vandamme MD, M. Simoens , I. Dero MD, W. Demey MD, T. Rondou , A. Cuypers , P. Abrams , C. Mattelaer , A. Driessen MD, PhD, B. Op De Beeck , O. D’Archambeau , G. Roeyen , L. De Backer , M. Peeters MD, PhD, NET specialists NETwerk Steering Committee
BJMO - 2017, issue 3, february 2017
B. De Laere , P. Van Oyen , C. Ghysel , P. Ost MD, PhD, W. Demey MD, L. Hoekx MD, D. Schrijvers MD, PhD, B. Brouwers MD, PhD, W. Lybaert MD, E. Everaert , J. Ampe , P. Van Kerckhove , D. De Maeseneer MD, M. Strijbos MD, PhD, A. Bols MD, PhD, K. Fransis , S. Oeyen , V. Van Dam , A. Brouwer , G. Van Den Eynden MD, PhD, A. Rutten MD, J. Vandebroek , S. Van Laere PhD, L. Dirix MD, PhD
Top
